Chang, Y., Lee, W., Lim, C., Wang, S., Hsu, S., Chen, Y., . . . Tseng, S. (2018). Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan. Nature Portfolio.
Cita Chicago Style (17a ed.)Chang, Yi-Sheng, et al. Real-world Use of Ranibizumab for Neovascular Age-related Macular Degeneration in Taiwan. Nature Portfolio, 2018.
Cita MLA (8a ed.)Chang, Yi-Sheng, et al. Real-world Use of Ranibizumab for Neovascular Age-related Macular Degeneration in Taiwan. Nature Portfolio, 2018.
Precaución: Estas citas no son 100% exactas.